Thoratec Corporation

Skip to content


The publications listed here are referenced within the website.

  • 1. American Heart Association. AHA Heart and Stroke Statistical Update. 2001.Back
  • 2. Hershberger RE, Nauman D, Walker TL, et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patient with refractory end-stage heart failure. J Card Fail. 2003;9(3):180-187.Back
  • 3. Miller L, et al. Use of a continuous-flow device in patients awaiting heart transplantation. NEJM. 2007;357:885-896.Back
  • 4. Park SJ, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9-17.Back
  • 5. Westaby S, et al. Elective transfer from cardiopulmonary bypass to centrifugal blood pump support in very high-risk cardiac surgery. J Thorac Cardiovasc Surg. 2007;133:577-578.Back
  • 6. Rose EA, Glejins AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. NEJM. 2001;345(20):1435-1443.Back
  • 7. Frazier OH, Rose EA, Oz MC, et al. Multi-center clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122(6):1186-1195.Back
  • 8. Russell SD, Miller LW, Pagani FD. Advanced Heart Failure: A Call To Action. Congestive Heart Failure. 2008; 14:316-321.Back
  • 9. Korfer R, el-Banayosy A, Posival H, et al. Mechanical circulatory support with the Thoratec assist device in patients with postcardiotomy cardiogenic shock. Ann Thoracic Surg. 1996;61(1):314-316.Back
  • 10. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation. 2005;112:e154-e235.Back
  • 11. Lietz K, Long J, Kfoury A, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era. Implications for patient selection. Circulation. 2007;116(5):497-505.Back
  • 12. Westaby S, Balacumaraswami L, Evans BJ, et al. Elective transfer from cardiopulmonary bypass in centrifugal blood pump support in very high-risk cardiac surgery. J Thorac Cardiovasc Surg. 2007;133(2):577-578.Back
  • 13. Zhang J, Gellman B, Koert A, et al. Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artif Organs. 2006;30(3):168-177.Back
  • 14. De Robertis F, Birks EJ, Barlow P, et al. End-stage cardiac failure managed with Levitronix CentriMag short-term ventricular assist device (VAD). J Heart Lung Transplant. 2005;24(2 suppl 1):559.Back
  • 15. Tsukui H, Teuteberg JJ, Murali S, et al. Biventricular assist device utilization for patients with morbid congestive heart failure: a justifiable strategy. Circulation. 2005;112(9 Suppl):I65-72.Back
  • 16. Slaughter MS, Sobieski MA, Martin M, et al. Home discharge experience with the Thoratec TLC-II portable driver. ASAIO J. 2007;53(2):132-135.Back
  • 17. Lazar RM, Shapiro PA, Jaski BE, et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004;109(20):2423-2427.Back
  • 18. Fries D, Innerhofer P, Streif W, et al. Coagulation monitoring and management of anticoagulation during cardiac assist device support. Ann Thorac Surg. 2003;76(5):1593-1597.Back
  • 19. Aaronson K, Eppinger M, Write S, Pagani FD. LVAD therapy improves utilization of donor hearts: implications for prolonged inotropic therapy. J Heart Lung Transplant. 2001;20(2):241.Back
  • 20. Butler K, Farrar D. No bearing wear detected in explanted clinical HeartMate II LVADs- implications for long-term durability and reliability. ASAIO J. 2006;52(2):33A.Back
  • 21. Drakos SG, Kfoury AG, Gilbert EM, et al. Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg. 2007;83:62-67.Back
  • 22. Data updated from sponsor presentation to FDA Circulatory System Devices Advisory Panel, November 30, 2007.Back
  • 23. Data from HeartMate II Left Ventricular Assist System Instructions for Use, April 2008.Back
  • 24. Data updated from sponsor presentation to FDA Circulatory System Devices Advisory Panel, November 30, 2007.Back
  • 25. Pagani FD, Miller,LW, Russell SD. Extended mechanical circulatory support with a continuous flow rotary left ventricular assist device. Journal of the American College of Cardiology. 2009;54:312-21.Back
  • 26. Data on file with Thoratec Corporation.Back
  • 27. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med.2009;361:2241-2251.Back
  • 28. Starling RC, Naka Y, et al. Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous-Flow Left Ventricular Assist Device as a Bridge to Transplantation. J Amer Coll Cardiol. 2011; 57: 1890-1898.Back
  • 29. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10.Back
  • 30. Teuteberg J, Lewis E, Nohria A, et al. Characteristics of patients who die with heart failure and low ejection fraction in the new millennium. J Card Fail. 2006;12(1):47-53.Back
  • 31. Kirsch, Matthias, et al. Survival after biventricular mechanical circulatory support: Does the type of device matter? J Heart Lung Transplant 2011; 31:501-8. Back
  • 32. Park, SJ et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012; 5(2):241-8. Back
  • 33. HeartMate PHP [instructions for use]. Pleasanton, CA; Thoratec Corporation; 2015. Back
  • 34. Data on file, Thoratec Corporation; 2015. Back
  • 35. Dur O, Fitzgerald K, Muller P, Parker C. In vitro pulsatile performance evaluation of the HeartMate percutaneous heart pump (PHP). Poster presented at: 61st Annual Conference of ASAIO; June 24-27, 2015; Chicago, IL. Abstract 216. Back
  • 36: Netuka I, Pya Y, Zimpfer D, et al. Multicenter study evaluating a fully magnetically levitated left ventricular assist system for the treatment of advanced heart failure: results from the CE Mark trial. Presented at the 19th Annual Meeting of the Heart Failure Society of America; September 26-29, 2015; Washington, DC. Back